Why the study?
Does unfractionated heparin or low molecular weight heparin combined with Gp IIb/IIIa blockers improve inhibition of platelet activation and aggregation in thrombin-stimulated platelets?
Population
Washed platelets stimulated with thrombin (in vitro model)
Comparison
Unfractionated heparin or low molecular weight… vs Absence of UFH, LMWH, and Gp IIb/IIIa blockers
Design
Preclinical
Authors
Loading...
In vitro UFH superiority over LMWH warrants no practice change; leaves open translation to clinical platelet inhibition with Gp IIb/IIIa blockers.
Does unfractionated heparin or low molecular weight heparin combined with Gp IIb/IIIa blockers improve inhibition of platelet activation and aggregation in thrombin-stimulated platelets?
In vitro, unfractionated heparin is more effective than low molecular weight heparin at inhibiting upstream platelet activation when coadministered with Gp IIb/IIIa blockers.
Jonathan Day (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: